Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG in COPD Outpatients With Frequent Exacerbations
NCT03018652Phase 2Completed
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Mar 2018
- Primary completion
- Nov 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of intravenous immunoglobulin G in chronic obstructive pulmonary disease (COPD), sponsored by Ottawa Hospital Research Institute. Started Mar 2018; status: completed.
02
Drugs
intravenous immunoglobulin G
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03018652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03018652.